Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer
Completed · Phase 4
Conditions studied: Non-small Cell Lung Cancer
In brief
The purpose of this study is to determine whether it is safe to treat lung cancer patients who have undergone an attempt at curative resection with the combination of docetaxel and carboplatin.
Key facts
- Study ID
- NCT00883675
- Run by
- Michael Mann
- People needed
- 133
- Starts
- 2009-05-01
- Expected to finish
- 2012-12-01
- Last updated by the study team
- 2013-12-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Non-small cell lung cancer stage IB - IIIA, complete resection with mediastinal lymph node dissection
- ECOG status 0-1
- >14 and <56 days since resection
You may not qualify if…
- Prior chemotherapy and/or radiation therapy for lung cancer
- Peripheral neuropathy > grade 1
- Concurrent other malignancies, other than basal cell or squamous cell carcinoma of the skin or carcinoma in situ of the cervix
- Medical condition that will not permit treatment or follow up according to the protocol
- Prior treatment with docetaxel or carboplatin
- Hypersensitivity to polysorbate 80, platinum-containing compounds or mannitol
- Treatment with other investigational anti-cancer drugs within 30 days of registration
- Pregnant or nursing women
- HIV-positive patients
Where it is running
- Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States
- Beijing Chaoyang Hospital — Beijing, China
- Beijing Tumor Hospital — Beijing, China
- Beijing Youyi Hospital — Beijing, China
- China-Japan Friendship Hospital — Beijing, China
- Xuanwu Hospital — Beijing, China
- First Affiliated Hospital, Guangzhou Medical College — Guangzhou, China
- Sun Yat-sen Cancer Center — Guangzhou, China
- Shanghai Chest Hopsital, Pulmonary Medicine — Shanghai, China
- Shanghai Lung Cancer Center, Shanghai Chest Hospital — Shanghai, China
- Shanghai Pulmonary Hospital — Shanghai, China
- Tianjin Cancer Center — Tianjin, China
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.